Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole for prevention of vaginal cellulitis after laparoscopic hysterectomy
NCT03917134Unknown
- Sponsor
- Universidad CES
- Start
- May 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial in Vaginal cellulitis and vaginal cuff abscess comparing Metronidazole Group with Placebo Group (2 arms). Primary endpoint: Incidence of cellulitis and vaginal cuff abscess at 30 days. Status: unknown.
02
Drugs
metronidazole
03
Conditions
Vaginal cellulitisvaginal cuff abscess
Beyond the preview
Go deeper on NCT03917134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03917134.